ArticleFrontiers in immunology2022

Case report: CD19-directed CAR-T cell therapy combined with BTK inhibitor and PD-1 antibody against secondary central nervous system lymphoma.

Wenqi Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.